The involvement of the recently described EGFR/HSP90/PPAR β/δ pathway in tumor cell metabolism, proliferation, and chemoresistance suggests a wider role of PPAR β/δ, one that includes cancer development and the resistance to therapy [48]. Here, EGFR is linked to neoplasm.